Maluf, F. C., Trindade, K., Almeida Preto, D. D., Marques Monteiro, F. S., Luz, M., Beato, P. M., … Fay, A. P. (2024). A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Maluf, Fernando Cotait, Karine Trindade, Daniel D. Almeida Preto, Fernando Sabino Marques Monteiro, Murilo Luz, Patricia Milhomem Beato, Diogo Assed Bastos, et al. “A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Maluf FC, Trindade K, Almeida Preto DD, Marques Monteiro FS, Luz M, Beato PM, et al. A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Maluf, Fernando Cotait, et al. “A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Maluf FC, Trindade K, Almeida Preto DD, Marques Monteiro FS, Luz M, Beato PM, Bastos DA, Holanda Soares JP, Lopes dos Santos VM, Werneck De Carvalho LE, Borges Muniz DQ, Racy D, Halabi S, Rebelatto TF, Werutsky G, de Jesus RG, Fay AP. A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. JOURNAL OF CLINICAL ONCOLOGY. 2024.